November 02, 2022
Cover Story
35
11
Increasing molecular diversity is creating a need for the reinvention of process development and control strategies.
November 02, 2022
Downstream Processing
35
11
A thorough knowledge of both the upstream and downstream processes is required to ensure effective removal of residual impurities in biopharmaceuticals.
November 02, 2022
Manufacturing
35
11
Pharma companies set goals and adopt more sustainable alternatives.
November 02, 2022
Development
35
11
Learning from early market failures, the biopharma industry has worked to improve the fate of antibody drug conjugates.
November 02, 2022
Upstream Processing
35
11
Experts reveal how to identify the “right” biochemical, the process of sourcing biochemicals, sourcing challenges, and what industry professionals should know about the space.
November 01, 2022
Quality/Regulations
35
11
Industry experts discuss best practices for certificates of analysis.
November 01, 2022
Outsourcing
35
11
In this article, the potential pitfalls of technology transfers are discussed as well as ways to ensure a smooth transition.
November 01, 2022
Manufacturing
35
11
Various advances in contamination control are being utilized to reduce the chance pollutants contaminate a drug product.
November 01, 2022
Regulatory Beat
35
11
FDA keeps its user fees but fails to gain important reforms.
November 01, 2022
From the CEO
35
11
Content is king in publishing, but interpretation is imperator.
November 01, 2022
Ask The Expert
35
11
Documentation is crucial to equipment qualification, says Siegfried Schmitt, vice president, Technical at Parexel.
November 01, 2022
From the CEO
35
11
Next year's "FDA Voices" series will cover core topics FDA staff are prioritizing.